vaccine without gelatin — Competitive Intelligence Brief

vaccine without gelatin (vaccine without gelatin) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Immunology.

marketed vaccine Immunology Biologic

Target snapshot

vaccine without gelatin (vaccine without gelatin) — Beijing Center for Disease Control and Prevention. A vaccine formulation that stimulates immune response without using gelatin as an excipient, making it suitable for patients with gelatin allergies or religious/dietary restrictions.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
vaccine without gelatin TARGET	vaccine without gelatin	Beijing Center for Disease Control and Prevention	marketed	vaccine
Comirnaty	BNT162b2 (tozinameran)	Pfizer Inc.	marketed	vaccine	SARS-CoV-2 virus	2021-08-23
Prevnar 20	pneumococcal 20-valent conjugate vaccine (PCV20)	Pfizer Inc.	marketed	Pneumococcal conjugate vaccine	Streptococcus pneumoniae capsular polysaccharides (20 serotypes)	2021-06-08
protein subunit: Novavax COVID-19 vaccine	protein subunit: Novavax COVID-19 vaccine	Novavax	marketed	Protein subunit vaccine	SARS-CoV-2 spike protein
Meningococcal A (control)	Meningococcal A (control)	International Vaccine Institute	marketed	polysaccharide vaccine	Neisseria meningitidis serogroup A capsular polysaccharide
A+C Vaccine	A+C Vaccine	Jiangsu Province Centers for Disease Control and Prevention	marketed	Polysaccharide conjugate vaccine	Neisseria meningitidis serogroups A and C polysaccharide capsule
domestic compared vaccine	domestic compared vaccine	Beijing Center for Disease Control and Prevention	marketed	vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2033-06-01 — Prevnar 20 · US 8,895,024 · Composition of matter · US
• 2035-06-01 — Prevnar 20 · US 10,279,033 · Method of use · US

Sponsor landscape (vaccine class)

1. Pfizer · 20 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
3. GlaxoSmithKline · 12 drugs in this class
4. Merck Sharp & Dohme LLC · 12 drugs in this class
5. Centers for Disease Control and Prevention · 9 drugs in this class
6. Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
7. Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
8. Beijing Center for Disease Control and Prevention · 6 drugs in this class
9. International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
10. Sinovac Biotech Co., Ltd · 4 drugs in this class